Eli Lilly, the global pharmaceutical giant, said the Therapeutic Goods Administration had approved the use of its Mounjaro ...

The market for weight-loss drugs could see new entrants among existing biotech firms, with several drug candidates likely to be approved ... s obesity market will grow, particularly in China ...

Eli Lilly shares jumped 15% after a clinical trial of its experimental pill showed it helped patients with Type 2 diabetes lose weight at levels comparable to leading injectable medications like ...

Discover the latest business news including rising gas prices, Zepbound shipments, At Home bankruptcy, and the Federal Reserve meeting.

Some drugs initially approved to treat Type 2 diabetes are now being used for cosmetic weight loss. WSJ’s Daniela Hernandez ... to hitting the market. Eli Lilly said its experimental pill ...

Eli Lilly, the drugmaker behind the blockbuster weight loss drug ... never been approved by the FDA. "Fella even tells patients that its untested oral drug is better than Lilly's approved ...

(Reuters) -Eli Lilly said on Sunday its drug Zepbound was superior to Novo Nordisk's Wegovy across five weight-loss targets such ... known as GLP-1 agonists approved to prevent major ...

Eli Lilly's stock boomed April 17 after announcing a new experimental pill that caused nearly 8% weight loss at certain dosages ... is a once-daily pill that, if approved, could be "readily ...

WASHINGTON (TNND) — Patients taking Eli Lilly’s drug ... more weight loss than semaglutide, which is the active ingredient in Wegovy and Ozempic. Researchers have said that all the approved ...

April 17 (UPI) --People diagnosed with type 2 diabetes might benefit soon from Eli Lilly's new orforglipron weight loss drug ... expected to be approved by the U.S. Food and Drug Administration ...